Influence of household pet ownership and filaggrin loss-of-function mutations on eczema prevalence in children: A birth cohort study.

Eczema Filaggrin Pet Rhinitis Wheezing

Journal

Allergology international : official journal of the Japanese Society of Allergology
ISSN: 1440-1592
Titre abrégé: Allergol Int
Pays: England
ID NLM: 9616296

Informations de publication

Date de publication:
31 Jan 2024
Historique:
received: 16 10 2023
revised: 05 12 2023
accepted: 04 01 2024
medline: 2 2 2024
pubmed: 2 2 2024
entrez: 1 2 2024
Statut: aheadofprint

Résumé

The association between pet exposure in infancy, early childhood eczema, and FLG mutations remains unclear. This was a birth cohort study performed in Tokyo, Japan. The primary outcome was current eczema based on questionnaire responses collected repeatedly from birth to 5 years of age. Generalized estimating equations and generalized linear modeling were used to evaluate the association. Data from 1448 participants were used for analyses. Household dog ownership during gestation, early infancy, and 18 months of age significantly reduced the risk of current eczema. Household cat ownership also reduced the risk of current eczema, albeit without statistical significance. The combined evaluation of children from households with pets, be it cats, dogs or both, the risk of current eczema at 1-5 years of age was lower in those with household pet exposure ownership during gestation (RR = 0.59, 95 % CI 0.45-0.77) and at 6 months (RR = 0.49, 95 % CI 0.36-0.68). , Reduced risks of eczema were also observed at 2-5 (RR = 0.52, 95 % CI 0.37-0.73) and 3-5 years of age (RR = 0.50 95 % CI 0.35-0.74) when the respective household pet ownership were evaluated at 18 months and 3 years of age. These protective associations of reduced risk of eczema were only observed in children without FLG mutations. Household dog and pet (dog, cat, or both) ownership was protective against early childhood eczema in a birth cohort dataset. This protective association was observed only in children without FLG mutations, which should be confirmed in studies with larger cohorts.

Sections du résumé

BACKGROUND BACKGROUND
The association between pet exposure in infancy, early childhood eczema, and FLG mutations remains unclear.
METHODS METHODS
This was a birth cohort study performed in Tokyo, Japan. The primary outcome was current eczema based on questionnaire responses collected repeatedly from birth to 5 years of age. Generalized estimating equations and generalized linear modeling were used to evaluate the association.
RESULTS RESULTS
Data from 1448 participants were used for analyses. Household dog ownership during gestation, early infancy, and 18 months of age significantly reduced the risk of current eczema. Household cat ownership also reduced the risk of current eczema, albeit without statistical significance. The combined evaluation of children from households with pets, be it cats, dogs or both, the risk of current eczema at 1-5 years of age was lower in those with household pet exposure ownership during gestation (RR = 0.59, 95 % CI 0.45-0.77) and at 6 months (RR = 0.49, 95 % CI 0.36-0.68). , Reduced risks of eczema were also observed at 2-5 (RR = 0.52, 95 % CI 0.37-0.73) and 3-5 years of age (RR = 0.50 95 % CI 0.35-0.74) when the respective household pet ownership were evaluated at 18 months and 3 years of age. These protective associations of reduced risk of eczema were only observed in children without FLG mutations.
CONCLUSIONS CONCLUSIONS
Household dog and pet (dog, cat, or both) ownership was protective against early childhood eczema in a birth cohort dataset. This protective association was observed only in children without FLG mutations, which should be confirmed in studies with larger cohorts.

Identifiants

pubmed: 38302328
pii: S1323-8930(24)00004-2
doi: 10.1016/j.alit.2024.01.003
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 Japanese Society of Allergology. Published by Elsevier B.V. All rights reserved.

Auteurs

Kenji Toyokuni (K)

Allergy Center, National Center for Child Health and Development, Tokyo, Japan; Department of Health and Psychosocial Medicine, Aichi Medical University School of Medicine, Aichi, Japan.

Kiwako Yamamoto-Hanada (K)

Allergy Center, National Center for Child Health and Development, Tokyo, Japan. Electronic address: yamamoto-k@ncchd.go.jp.

Limin Yang (L)

Allergy Center, National Center for Child Health and Development, Tokyo, Japan.

Kouhei Hagino (K)

Allergy Center, National Center for Child Health and Development, Tokyo, Japan.

Daisuke Harama (D)

Allergy Center, National Center for Child Health and Development, Tokyo, Japan.

Marei Omori (M)

Allergy Center, National Center for Child Health and Development, Tokyo, Japan.

Yasuaki Matsumoto (Y)

Allergy Center, National Center for Child Health and Development, Tokyo, Japan.

Daichi Suzuki (D)

Allergy Center, National Center for Child Health and Development, Tokyo, Japan.

Kotaro Umezawa (K)

Allergy Center, National Center for Child Health and Development, Tokyo, Japan.

Kazuma Takada (K)

Allergy Center, National Center for Child Health and Development, Tokyo, Japan.

Mami Shimada (M)

Allergy Center, National Center for Child Health and Development, Tokyo, Japan.

Seiko Hirai (S)

Allergy Center, National Center for Child Health and Development, Tokyo, Japan.

Fumi Ishikawa (F)

Allergy Center, National Center for Child Health and Development, Tokyo, Japan; Department of Health and Psychosocial Medicine, Aichi Medical University School of Medicine, Aichi, Japan.

Sayaka Hamaguchi (S)

Allergy Center, National Center for Child Health and Development, Tokyo, Japan.

Mayako Saito-Abe (M)

Allergy Center, National Center for Child Health and Development, Tokyo, Japan.

Miori Sato (M)

Allergy Center, National Center for Child Health and Development, Tokyo, Japan; Department of Health and Psychosocial Medicine, Aichi Medical University School of Medicine, Aichi, Japan.

Yumiko Miyaji (Y)

Allergy Center, National Center for Child Health and Development, Tokyo, Japan.

Shigenori Kabashima (S)

Allergy Center, National Center for Child Health and Development, Tokyo, Japan.

Tatsuki Fukuie (T)

Allergy Center, National Center for Child Health and Development, Tokyo, Japan.

Emiko Noguchi (E)

Department of Medical Genetics, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan.

Kohta Suzuki (K)

Department of Health and Psychosocial Medicine, Aichi Medical University School of Medicine, Aichi, Japan.

Yukihiro Ohya (Y)

Allergy Center, National Center for Child Health and Development, Tokyo, Japan.

Classifications MeSH